Free Trial
NYSEAMERICAN:IGC

IGC Pharma (IGC) Stock Price, News & Analysis

$0.44 +0.01 (+3.25%)
As of 04:10 PM Eastern

About IGC Pharma Stock (NYSEAMERICAN:IGC)

Key Stats

Today's Range
$0.44
$0.46
50-Day Range
N/A
52-Week Range
$0.25
$0.50
Volume
1.03 million shs
Average Volume
1.31 million shs
Market Capitalization
$40.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.50
Consensus Rating
Buy

Company Overview

IGC Pharma Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
59th Percentile Overall Score

IGC MarketRank™: 

IGC Pharma scored higher than 59% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    IGC Pharma has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    IGC Pharma has only been the subject of 1 research reports in the past 90 days.

  • Read more about IGC Pharma's stock forecast and price target.
  • Price to Book Value per Share Ratio

    IGC Pharma has a P/B Ratio of 6.36. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.21% of the outstanding shares of IGC Pharma have been sold short.
  • Short Interest Ratio / Days to Cover

    IGC Pharma has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in IGC Pharma has recently decreased by 17.29%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    IGC Pharma does not currently pay a dividend.

  • Dividend Growth

    IGC Pharma does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.21% of the outstanding shares of IGC Pharma have been sold short.
  • Short Interest Ratio / Days to Cover

    IGC Pharma has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in IGC Pharma has recently decreased by 17.29%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    IGC Pharma has a news sentiment score of 1.28. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.56 average news sentiment score of Manufacturing companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for IGC Pharma this week, compared to 0 articles on an average week.
  • Search Interest

    Only 2 people have searched for IGC on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, IGC Pharma insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    23.66% of the stock of IGC Pharma is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 3.87% of the stock of IGC Pharma is held by institutions.

  • Read more about IGC Pharma's insider trading history.
Receive IGC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IGC Pharma and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IGC Stock News Headlines

See More Headlines

IGC Stock Analysis - Frequently Asked Questions

IGC Pharma's stock was trading at $0.39 at the beginning of 2025. Since then, IGC shares have increased by 14.1% and is now trading at $0.4450.

Shares of IGC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that IGC Pharma investors own include GW Pharmaceuticals (GWPH), Alibaba Group (BABA), Tilray Brands (TLRY), Cronos Group (CRON), Micron Technology (MU) and NewAge (NBEV).

Company Calendar

Today
9/02/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSEAMERICAN:IGC
CIK
1326205
Web
N/A
Employees
61
Year Founded
N/A

Price Target and Rating

High Price Target
$4.50
Low Price Target
$4.50
Potential Upside/Downside
+911.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.12 million
Net Margins
-478.82%
Pretax Margin
-477.92%
Return on Equity
-97.59%
Return on Assets
-70.33%

Debt

Debt-to-Equity Ratio
0.02
Current Ratio
1.25
Quick Ratio
0.47

Sales & Book Value

Annual Sales
$1.27 million
Price / Sales
31.82
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.08 per share
Price / Book
5.56

Miscellaneous

Outstanding Shares
90,810,000
Free Float
69,324,000
Market Cap
$40.41 million
Optionable
N/A
Beta
1.08
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NYSEAMERICAN:IGC) was last updated on 9/2/2025 by MarketBeat.com Staff
From Our Partners